Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 3Observational 2

Sponsor

Conditions

Arthritis, Rheumatoid 2

Interventions

Etanercept 6Adalimumab 6Infliximab 5tocilizumab 3golimumab 3Tumor Necrosis Factor Inhibitors 3tofacitinib 2Rituximab 2Certolizumab Pegol 2Surveys and Questionnaires 1Standard of Care 1Practice Guidelines as Topic 1Phlebotomy 1Observation 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1Dietary Fiber 1CT-P13 1Antirheumatic Agents 1Abatacept 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Arthritis, Rheumatoid × tofacitinib × Clear all
NCT04721821 2024-04-12

Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy.

Pfizer

Completed
7,807 enrolled 73 charts

Arthritis, Rheumatoid

NCT04798287 2022-06-22

STAR-RA-Cancer

Brigham and Women's Hospital

Completed
105,711 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡